Category: Pharmaceuticals
The US FDA (Food & Drug Administration) has reportedly given approval to a new osteoporosis drug, which is called Evenity (the brand name) or romosozumab, for the treatment of …
Swiss drug-maker Novartis and U.S.-based biotechnology company Amgen Inc. are reportedly ensnared in a major dispute over their joint venture deal for the migraine prevention drug – Aimovig. Reports …
The QIAGEN’s initiative, called Day-One, is specifically designed to provide patients a faster access to newly-approved precision medicines With the collaboration agreement, LabCorp becomes the latest firm to join …
Atara Biotherapeutics, the California-based allogeneic T-cell immunotherapy company, that is known for developing original treatments for patients suffering from cancer, viral and autoimmune diseases, recently announced that its collaborators …
AstraZeneca will fund the transaction partly from the proceeds of a new equity placement of up to $3.5 billion. AstraZeneca Plc has agreed to pay up to $6.9 billion …
NASH is a complex medical condition for which multimodal treatments are required to treat the complete range of patients DURECT Corporation has reportedly announced that it has started the …
Mayzent is anticipated to be launched in the United States in about a week Novartis AG has reportedly gained approval from the US FDA (Food & Drug Administration) for …
Menlo Therapeutics has reportedly got its Phase 2 clinical trial data pertaining to the use of serlopitant to treat pruritus linked to prurigo nodularis (PN) published in the Journal …
Ascendis Pharma, a renowned biopharmaceutical firm which utilizes its state-of-the-art TransCon technology to deal with unmet therapeutic needs, has recently declared top-line outcomes from its main phase III heiGHt …
Biogen Inc., the U.S.-based biotechnology industry major, has apparently halted two significant Phase 3 trials intended for testing the Alzheimer’s drug Aducanumab, which has recently delivered sheer disappointment to …
